Hence, inhibition of energy metabolism might constitute a useful strategy to target BRCA1-deficient high grade serous ovarian cancer, a type of tumor characterized by frequent BRCA1 loss (69). The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.